MiMedx CFO receives shares via PSU vesting

MiMedx Group Chief Financial Officer Doug Rice reported equity compensation activity tied to performance stock units (PSUs).

Rhea-AI Filing Summary

MiMedx Group Chief Financial Officer Doug Rice reported equity compensation activity tied to performance stock units (PSUs). On the reported date, he acquired 243,000 shares of common stock at $4.50 per share upon vesting of PSUs covering the performance period from January 1, 2023 to December 31, 2025.

In connection with this vesting, 96,363 shares were disposed of at $4.50 per share to satisfy tax obligations, with shares withheld as required by company policy rather than sold on the open market. After these transactions, Rice directly held 412,315 shares of MiMedx common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider DOUG RICE

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Common Stock	243,000	$4.50	$1.09M
Exercise Price or Tax Liability	Common Stock	96,363	$4.50	$434K

Holdings After Transaction: Common Stock — 412,315 shares (Direct)

Footnotes (2)

1. F1. Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on July 5, 2023.
2. F2. The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MiMedx (MDXG) CFO Doug Rice report in this Form 4?

MiMedx CFO Doug Rice reported PSU-related equity activity. He received 243,000 common shares from performance stock unit vesting and had 96,363 shares withheld to cover tax obligations, all under company policy as compensation rather than open-market trading.

How many MiMedx (MDXG) shares did the CFO receive from PSU vesting?

Doug Rice received 243,000 MiMedx common shares at $4.50 per share from the vesting of performance stock units covering the January 1, 2023 to December 31, 2025 performance period, reflecting previously granted long-term incentive compensation.

Were any MiMedx (MDXG) shares sold on the market in this Form 4?

The filing shows 96,363 shares disposed at $4.50 per share, but footnotes clarify these were shares withheld to pay tax liabilities upon PSU vesting under company policy, not open-market sales initiated by the CFO.

How many MiMedx (MDXG) shares does the CFO hold after these transactions?

Following the PSU vesting and related tax withholding, Doug Rice directly holds 412,315 shares of MiMedx common stock. This reflects his updated ownership position after the compensation-related equity activity reported in the Form 4.

What performance period did the MiMedx (MDXG) PSUs cover for the CFO?

The performance stock units that vested for Doug Rice covered the period from January 1, 2023 to December 31, 2025. These PSUs were originally granted on July 5, 2023, and vested based on that multi-year performance timeframe.

How were taxes handled on the MiMedx (MDXG) PSU vesting for the CFO?

Taxes were satisfied by withholding 96,363 shares in connection with the PSU vesting. Footnotes explain this withholding was required by company policy and used for tax liability payment, rather than being discretionary market sales by the CFO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 05:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DOUG RICE

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT NE

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		243,000(1)	A	$4.5	508,678	D
Common Stock	03/10/2026		F		96,363(2)	D	$4.5	412,315	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on July 5, 2023.

2. The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting.

Remarks:

	William F. Hulse, as attorney-in-fact for Doug Rice	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.